Published • loading... • Updated
Novo Nordisk invests further in Tianjin production hub
Summary by ScandAsia
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Novo Nordisk invests further in Tianjin production hub
Danish pharmaceutical company Novo Nordisk has announced plans to invest an additional 200 million yuan (US$29.4 million) in its production facility in Tianjin, China, expanding both drug manufacturing and injection … The post Novo Nordisk invests further in Tianjin production hub appeared first on Scandasia.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
